Safety of Statins in Chronic Hepatitis B Patients

Am J Gastroenterol. 2017 Feb;112(2):385-386. doi: 10.1038/ajg.2016.578.

Authors

Yi-Wen Huang^{1

2

3

4}, An-Chi Hsieh¹, Sien-Sing Yang^{1

5}

Affiliations

¹ Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
² School of Medicine, Taipei Medical University College of Medicine, Taipei, Taiwan.
³ Division of Gastroenterology, Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
⁴ School of Medicine, China Medical University, Taichung, Taiwan.
⁵ School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan.

PMID: 28154403
DOI: 10.1038/ajg.2016.578

No abstract available

Publication types

Comment

MeSH terms

Antiviral Agents
Hepatitis B virus
Hepatitis B, Chronic*
Hepatitis C, Chronic
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Treatment Outcome

Substances

Antiviral Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors